Identification of Fromiamycalin and Halaminol A from Australian Marine Sponge Extracts with Anthelmintic Activity against Haemonchus contortus

Marine Drugs

卷:17

Sarah Preston¹  Robin B. Gasser¹  H. M. P. Dilrukshi Herath¹  Bill C. H. Chang¹  Aya C. Taki¹  Jose Garcia-Bustos¹  Andreas Hofmann¹  Abdul Jabbar¹  Sasha Hayes²  Rohan A. Davis²  Karren D. Beattie²  Russell S. Addison²  Sean L. McGee³  Sheree D. Martin³  John N. A. Hooper⁴  Merrick G. Ekins⁴ 

[1] Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia;

[2] Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia;

[3] Metabolic Research Unit, Metabolic Reprogramming Laboratory, School of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria 3216, Australia;

[4] Queensland Museum, South Brisbane BC, QLD 4101, Australia;

关键词: marine;    anthelmintic;    haemonchus contortus;    alkaloid;    fromiamycalin;    halaminol a;    monanchora unguiculata;    haliclona sp;   

DOI  :  10.3390/md17110598

来源: DOAJ

【 摘 要 】

There is an urgent need to discover and develop new anthelmintics for the treatment of parasitic nematodes of veterinary importance to circumvent challenges linked to drug resistant parasites. Being one of the most diverse natural ecosystems, the marine environment represents a rich resource of novel chemical entities. This study investigated 2000 extracts from marine invertebrates, collected from Australian waters, for anthelmintic activity. Using a well-established in vitro bioassay, these extracts were screened for nematocidal activity against Haemonchus contortus — a socioeconomically important parasitic nematode of livestock animals. Extracts (designated Mu-1, Ha-1 and Ha-2) from two marine sponges (Monanchora unguiculata and Haliclona sp.) each significantly affected larvae of H. contortus. Individual extracts displayed a dose-dependent inhibition of both the motility of exsheathed third-stage larvae (xL3s) and the development of xL3s to fourth-stage larvae (L4s). Active fractions in each of the three extracts were identified using bioassay-guided fractionation. From the active fractions from Monanchora unguiculata, a known pentacyclic guanidine alkaloid, fromiamycalin (1), was purified. This alkaloid was shown to be a moderately potent inhibitor of L4 development (half-maximum inhibitory concentration (IC₅₀) = 26.6 ± 0.74 µM) and L4 motility (IC₅₀ = 39.4 ± 4.83 µM), although it had a relatively low potency at inhibiting of xL3 motility (IC₅₀ ≥ 100 µM). Investigation of the active fractions from the two Haliclona collections led to identification of a mixture of amino alcohol lipids, and, subsequently, a known natural product halaminol A (5). Anthelmintic profiling showed that 5 had limited potency at inhibiting larval development and motility. These data indicate that fromiamycalin, other related pentacyclic guanidine alkaloids and/or halaminols could have potential as anthelmintics following future medicinal chemistry efforts.

【 授权许可】

Unknown